MoneyWorks4Me

Brawn Biotech - Quaterly Results

25 May 2022 Evaluate
A decrease in the sales to Rs. 28.87 millions was observed for the quarter ended March 2022. The sales stood at Rs. 30.62 millions during the similar quarter previous year.The Total Profit for the quarter ended March 2022 of Rs. 6.30 millions grew from Rs.-6.04 millions Operating profit Margin for the quarter ended March 2022 improved to 1.81% as compared to -3.85% of corresponding quarter ended March 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 28.87 30.62 -5.72 86.21 349.76 -75.35 86.21 349.76 -75.35
Other Income -0.88 3.09 -128.48 0.03 3.09 -99.03 0.03 3.09 -99.03
PBIDT 1.81 -3.85 -147.01 -20.02 -2.88 595.14 -20.02 -2.88 595.14
Interest 0.05 0.20 -75.00 0.63 0.37 70.27 0.63 0.37 70.27
PBDT 1.76 -4.05 -143.46 -20.65 -3.25 535.38 -20.65 -3.25 535.38
Depreciation 0.20 0.08 150.00 0.53 0.34 55.88 0.53 0.34 55.88
PBT 1.56 -4.13 -137.77 -21.18 -3.59 489.97 -21.18 -3.59 489.97
TAX -4.74 1.91 -348.17 -4.74 1.91 -348.17 -4.74 1.91 -348.17
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 6.30 -6.04 -204.30 -16.44 -5.50 198.91 -16.44 -5.50 198.91
Equity 30.00 30.00 0.00 30.00 30.00 0.00 30.00 30.00 0.00
PBIDTM(%) 6.27 -12.57 -149.86 -23.22 -0.82 2720.31 -23.22 -0.82 2720.31
Peers